Bumetanide and Paclitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Paclitaxel (paclitaxel). Common drug interactions include neutropenic sepsis among females and lymphangiosis carcinomatosa among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Paclitaxel. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

On Jul, 10, 2026

33 people who take Bumetanide and Paclitaxel together, and have interactions are studied.

Bumetanide and Paclitaxel drug interactions.

What are the common drug interactions of Bumetanide and Paclitaxel, by gender? *:

female:

Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
General physical health deterioration (weak health status)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Anaemia (lack of blood)
Pneumonia
Blood potassium decreased
Gamma-glutamyltransferase increased
Neoplasm progression (growth of tumour)
Staphylococcus test positive
White blood cell count decreased

male:

Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
Prostate cancer
Productive cough
Malignant neoplasm progression (cancer tumour came back)
Anxiety
Asthenia (weakness)
Death
Diarrhoea
Disease progression
Fatigue (feeling of tiredness)

What are the common drug interactions of Bumetanide and Paclitaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Febrile neutropenia (fever with reduced white blood cells)

30-39:

n/a

40-49:

Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
Prostate cancer
Malignant neoplasm progression (cancer tumour came back)
Disease progression

50-59:

Dehydration (dryness resulting from the removal of water)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Lymphocyte count decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Fatigue (feeling of tiredness)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Hypokalaemia (low potassium)
Pleural effusion (water on the lungs)

60+:

Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
General physical health deterioration (weak health status)
Dyspnoea (difficult or laboured respiration)
Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
Pneumonia
Pulmonary mass
Body temperature increased
Headache (pain in head)
Urticaria (rash of round, red welts on the skin that itch intensely)
Vision blurred

What are the existing conditions these people have? *

Endometrial Cancer: 10 people, 30.30%
High Blood Pressure: 10 people, 30.30%
Pain: 9 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 24.24%
Constipation: 8 people, 24.24%
Abdominal Pain Lower: 7 people, 21.21%
Back Pain: 7 people, 21.21%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 7 people, 21.21%
Oedema Peripheral (superficial swelling): 6 people, 18.18%
Nausea (feeling of having an urge to vomit): 6 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Paclitaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously